Department of Clinical and Experimental Medicine, University of Foggia, 70122 Foggia, Italy.
Consorzio Interuniversitario Nazionale per la Bio-Oncologia (C.I.N.B.O.), 66100 Chieti, Italy.
Int J Environ Res Public Health. 2021 Oct 19;18(20):11001. doi: 10.3390/ijerph182011001.
Reinfection with SARS-CoV-2 seems to be a rare phenomenon. The objective of this study is to carry out a systematic search of literature on the SARS-CoV-2 reinfection in order to understand the success of the global vaccine campaigns. A systematic search was performed. Inclusion criteria included a positive RT-PCR test of more than 90 days after the initial test and the confirmed recovery or a positive RT-PCR test of more than 45 days after the initial test that is accompanied by compatible symptoms or epidemiological exposure, naturally after the confirmed recovery. Only 117 articles were included in the final review with 260 confirmed cases. The severity of the reinfection episode was more severe in 92/260 (35.3%) with death only in 14 cases. The observation that many reinfection cases were less severe than initial cases is interesting because it may suggest partial protection from disease. Another interesting line of data is the detection of different clades or lineages by genome sequencing between initial infection and reinfection in 52/260 cases (20%). The findings are useful and contribute towards the role of vaccination in response to the COVID-19 infections. Due to the reinfection cases with SARS-CoV-2, it is evident that the level of immunity is not 100% for all individuals. These data highlight how it is necessary to continue to observe all the prescriptions recently indicated in the literature in order to avoid new contagion for all people after healing from COVID-19 or becoming asymptomatic positive.
再次感染 SARS-CoV-2 似乎是一种罕见的现象。本研究旨在对 SARS-CoV-2 再次感染的文献进行系统检索,以了解全球疫苗接种运动的成功。进行了系统检索。纳入标准包括初始检测后 90 天以上的 RT-PCR 检测呈阳性且已确认康复,或初始检测后 45 天以上的 RT-PCR 检测呈阳性且伴有相符症状或流行病学暴露,且在确认康复后自然发生。最终审查中仅纳入了 117 篇文章,其中包括 260 例确诊病例。在 260 例确诊病例中,92 例(35.3%)再次感染病例的严重程度更严重,仅 14 例死亡。观察到许多再次感染病例的严重程度不如初次感染病例,这很有趣,因为这可能表明疾病存在一定程度的保护。另一个有趣的数据是,在 52 例(20%)初次感染和再次感染之间通过基因组测序检测到不同的分支或谱系。这些发现具有一定的参考价值,有助于阐明疫苗接种在应对 COVID-19 感染中的作用。由于再次感染 SARS-CoV-2 的病例,很明显,并非所有个体的免疫水平都是 100%。这些数据强调了为何有必要继续观察文献中最近指出的所有规定,以避免所有 COVID-19 治愈或无症状阳性患者在康复后再次发生感染。